A randomized, prospective, placebo-controlled double-blind, pilot study on the effect of Cilostazol for 4 weeks in patients with chronic tinnitus
Not Applicable
Completed
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0000128
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Adults of age over 19
Unilateral or bilateral tinnitus
Chronic tinnitus lasting more than 3 months
Initial visual analogue scale of tinnitus >3
Exclusion Criteria
Conductive hearing loss on pure tone audiometry
Associated other inner ear diseases such as Meniere’s disease
Objective or pulsatile tinnitus
Contraindication to anti-platelet drug
Any cardiac disease accompanying risk of thromboembolism
Bleeding tendency and major operation within 3 months
Breastfeeding
Pregnancy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tinnitus handicap inventory
- Secondary Outcome Measures
Name Time Method visual analogue scale;Quality of life SF-36